Novo Banco SA, a Portuguese lender that’s majority-owned by Lone Star, said its planned initial public offering could take ...

LISBON (Reuters) -Novo Banco, Portugal's fourth-largest lender, reported a record net profit of 744.6 million euros ($804 million) on Thursday, ahead of a planned initial public offering ...

Portugal's fourth-largest lender Novo Banco, which is preparing for an initial public offering (IPO), said on Thursday its consolidated net profit hit a record 744.6 million euros ($804 million) in ...

Portuguese state-owned bank Caixa Geral de Depositos SA is analyzing the possible acquisition of Novo Banco SA, a smaller lender that’s preparing an initial public offering. “We are analyzing ...

LISBON (Reuters) - Portugal's fourth-largest lender Novo Banco, which is preparing for an initial public offering (IPO), said ...

More Bonds of Banco Espírito Santo S.A. [Luxembourg Branch] Moody’s Daily Credit Risk Score About the Banco Espírito Santo S.A. [Luxembourg Branch]-Bond (XS1034421419) The Banco Espírito ...

Europe’s largest pharmaceutical firm, Novo Nordisk, has announced that it will offer its most popular weight-loss drug, Wegovy, for less than half of its listed price. This follows a similar ...

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight ...

Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...

Novo Nordisk stock has fallen roughly 40% from a peak it reached last June. The U.S. Food and Drug Administration recently confirmed Novo Nordisk is producing enough Ozempic and Wegovy to meet ...

Danish drugmaker Novo Nordisk (NVO) said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of $499, down from $650, takes effect immediately. Novo said the new ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its direct-to-patient online pharmacy, as competition in the highly ...